Albuminated PLGA nanoparticles containing bevacizumab intended for ocular neovascularization treatment

Publisher： John Wiley & Sons Inc

E-ISSN： 1552-4965|103|10|3148-3156

ISSN： 1549-3296

Source： Journal Of Biomedical Materials Research. Part A, Vol.103, Iss.10, 2015-10, pp. : 3148-3156

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Post-culture treatment protocols for PLGA membrane scaffolds

By Ellis Marianne   Forsey Richard   Chaudhuri Julian  

Biotechnology Letters, Vol. 32, Iss. 2, 2010-02 ,pp. : 215-222

Springer Publishing Company

Access to resources Recommend Favorite

Cytotoxicity and intracellular fate of PLGA and chitosan‐coated PLGA nanoparticles in Madin–Darby bovine kidney (MDBK) and human colorectal adenocarcinoma (Colo 205) cells

By  

Journal Of Biomedical Materials Research. Part A, Vol. 103, Iss. 11, 2015-11 ,pp. : 3599-3611

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of growth plate injury using IGF‐I‐loaded PLGA scaffolds

By  

Journal Of Tissue Engineering And Regenerative Medicine, Vol. 9, Iss. 12, 2015-12 ,pp. : E202-E209

John Wiley & Sons Inc

Access to resources Recommend Favorite

Minimal In Vitro Antimicrobial Efficacy and Ocular Cell Toxicity from Silver Nanoparticles

By Santoro Colleen  

Nanobiotechnology, Vol. 3, Iss. 2, 2007-05 ,pp. : 55-65

Humana Press, Inc

Access to resources Recommend Favorite

Biocompatibility and osteogenesis of calcium phosphate composite scaffolds containing simvastatin‐loaded PLGA microspheres for bone tissue engineering

By  

Journal Of Biomedical Materials Research. Part A, Vol. 103, Iss. 10, 2015-10 ,pp. : 3250-3258

John Wiley & Sons Inc

Access to resources Recommend Favorite